IP Library Granted Patent US 12,478,566
Granted Patent B2
US 12,478,566 · App. 18/647,063 · Granted Nov 25, 2025

Color stable skin benefit compositions

Inventors: Anjing Lou (Seymour, CT); Congling Quan (Woodbridge, CT); William Zavoluk (Milford, CT); Teanoosh Moaddel (Watertown, CT)
Assignee: Conopco, Inc.
A61K8/068A61K8/345A61K8/671A61K8/92A61Q19/08A61K2800/10A61K2800/413A61K2800/524B82Y5/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,478,566
App. No.
18/647,063
Granted
Nov 25, 2025
Kind
B2
Abstract

Nanoemulsions as emulsion additives are prepared to stabilize actives and prevent formulation discoloration. The nanoemulsions have at least 30% by weight oil and are suitable to add to emulsions and/or structured water to produce color stable end use skin benefit compositions.

Claims (22)

1 . A method for improving color stability of an end use composition by reducing discoloration originating from active comprising 4-ethyl resorcinol, 4-hexyl resorcinol or both, and retinyl propionate, retinol or both present in the end use composition, the method comprising the steps of:

a) preparing a water continuous nanoemulsion by mixing with homogenization at a pressure from 1,500 to 6,000 psi (a) the active; (b) water; (c) water soluble humectant (d) oil; and (e) emulsifier, wherein:

i) the active is soluble in the oil;

ii) oil as particle in the nanoemulsion has a particle size from 0.05 to less than 1.5 microns; and

iii) the nanoemulsion comprises at least 30% by weight oil;

b) combining the nanoemulsion with an emulsion chassis, the emulsion chassis being water continuous; and

c) shearing the nanoemulsion and emulsion chassis after combining to produce the end use composition; and

d) recovering the end use composition, wherein the nanoemulsion makes up from 25 to 60% by weight of the end use composition and the end use composition is water continuous.

2 . The method according to claim 1 wherein the end use composition is a cream, lotion, balm, or serum.

3 . The method according to claim 1 wherein the active comprises retinyl propionate and 4-hexyl resorcinol.

4 . The method according to claim 1 wherein the active consists essentially of retinyl propionate and 4-hexyl resorcinol.

5 . The method according to claim 1 wherein the end use composition further comprises vitamin B2, niacinamide, vitamin B6, vitamin C, vitamin E, tocopherol acetate, folic acid, biotin, vitamin D, vitamin K, DL-panthenol or a mixture thereof.

6 . The method according to claim 1 wherein the end use composition further comprises alpha hydroxy acid, beta hydroxy acid, 12-hydroxystearic acid, petroselinic acid, conjugated linoleic acid, creatine, creatinine, retinoid booster, sunscreen or a mixture thereof.

7 . The method according to claim 6 wherein the end use composition does comprise retinoid booster and the retinoid booster is climbazole, bifonazole, farnesole, glycyrrchetinic acid, ursolic acid, geranyl geraniol, oleyl betaine, hexanoyl sphingosine or a mixture thereof.

8 . The method according to claim 1 wherein the end use composition further comprises iodopropynyl butyl carbamate, phenoxyethanol, hydoxyacetophenone, 1,2-octanediol, ethylhexylglycerine, hexylene glycol, or a mixture thereof.

9 . The method according to claim 1 wherein the end use composition has a pH from 6 to 7.5 and a viscosity from 5 to 20,000 cps.

10 . The method according to claim 1 wherein the emulsifier has an HLB from 7 to 17 and the nanoemulsion comprises from 1 to 35% by weight humectant comprising glycerine.

11 . The method according to claim 1 wherein the end use composition comprises glycerin, 4-hexyl resorcinol and retinol, and further comprises 1,2-octanediol, ethylhexylglycerin, phenoxyethanol, cetyl alcohol, propylene glycol, 1,3 butylene glycol, or a mixture thereof.

12 . An end use composition made by the method of claim 1 .

13 . The method according to claim 3 wherein the end use composition further comprises niacinamide, vitamin K or both.

14 . The method according to claim 3 wherein the end use composition further comprises 12-hydroxystearic acid.

15 . The end use composition according to claim 12 wherein the end use composition comprises niacinamide, retinyl propionate and 4-hexyl resorcinol.

Assignments (2)
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNOR: WILLIAM ZAOLUK NAME NEEDS TO BE CHANGED PREVIOUSLY RECORDED ON REEL 67369 FRAME 243. ASSIGNOR(S) HEREBY CONFIRMS THE CHANGE OF NAME. Recorded Jun 27, 2024
From: LOU, ANJING; QUAN, CONGLING; ZAVOLUK, WILLIAM; MOADDEL, TEANOOSH
To: CONOPCO, INC., D/B/A UNILEVER
Reel/Frame 067936/0837 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 10, 2024
From: LOU, ANJING; QUAN, CONGLING; ZAOLUK, WILLIAM; MOADDEL, TEANOOSH
To: CONOPCO, INC., D/B/A UNILEVER
Reel/Frame 067369/0243 →
Priority Claims (1)
EP 17180848 · Jul 12, 2017 · regional
Continuity (2)
Continuation 16630140
Related Publication 20240285486A1 · Aug 29, 2024
References Cited (3)
US 11540984B2 · Lou · 2023 [cited by examiner]
US 20210205186A1 · Lou · 2021 [cited by examiner]
US 20220151886A1 · Lou · 2022 [cited by examiner]